clinical_trials
Gene Therapy Under Scrutiny After Nine Tumor Reports
Confidence86·multiple reportsImportance88NP-EVT-20261106-FA2E050
(MedPage Today) -- Drugmaker Novartis acknowledged Thursday that there have been nine reports of tumors in children treated with its gene therapy onasemnogene abeparvovec (Zolgensma) for spinal muscular atrophy (SMA). Two of the tumor cases were...
Read the original at the primary source
Gene Therapy Under Scrutiny After Nine Tumor Reports
11/6/2026, 10:27:17 PM
Also on the network: airlinesairports · farmerspulse · foodpulse · indianhealthpulse · indias · keralahealth · naturepulse · travelerpulse
Discussion
ChatsPulse · 0 threads
No discussion yet. Sign in and start the first thread —